Skip to main content

Prototype Prescribing Outlier Dashboard for Hackenthorpe Medical Centre

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Hackenthorpe Medical Centre is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Stiripentol 31 Control of epilepsy 2,950 0.01 0.00 0.00 16.53
Alkyl sulfate 18 Shampoos and some other scalp preparations 212 0.08 0.00 0.01 13.35
Olmesartan medoxomil/hydrochlorothiazide 34 Angiotensin-II receptor antagonists 1,555 0.02 0.00 0.00 8.04
Simvastatin and ezetimibe 32 Lipid-regulating drugs 8,529 0.00 0.00 0.00 5.85
Dequalinium chloride 2 Vaginal and vulval infections 82 0.02 0.00 0.01 4.60
Telmisartan with diuretic 29 Angiotensin-II receptor antagonists 1,555 0.02 0.00 0.00 4.38
Sodium zirconium cyclosilicate 7 Oral potassium 17 0.41 0.02 0.10 4.13
Chloral hydrate 23 Hypnotics 788 0.03 0.00 0.01 4.13
Valsartan with diuretic 38 Angiotensin-II receptor antagonists 1,555 0.02 0.00 0.01 4.03
Insulin Lispro 79 Short-acting insulins 144 0.55 0.16 0.10 3.83

Prescribing where Hackenthorpe Medical Centre is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Insulin aspart 61 Short-acting insulins 144 0.42 0.79 0.11 -3.24
Potassium chloride 10 Oral potassium 17 0.59 0.96 0.14 -2.69
Oral rehydration salts 1 Oral sodium and water 31 0.03 0.71 0.29 -2.31
Venlafaxine 165 Other antidepressant drugs 2,381 0.07 0.26 0.09 -2.11
Insulin glargine 27 Intermediate and long-acting insulins 467 0.06 0.33 0.13 -2.08
Carbomer 940/980 13 Tear deficiency, eye lubricant/astringent 319 0.04 0.34 0.15 -2.01
Quinine sulfate 186 Antimalarials 289 0.64 0.90 0.14 -1.86
Estradiol with progestogen 54 Oestrogens and Hormone Replacement Therapy 317 0.17 0.39 0.12 -1.86
Clarithromycin 62 Macrolides 218 0.28 0.57 0.16 -1.81
Mupirocin 0 Antibacterial preparations only used topically 4 0.00 0.64 0.36 -1.79